Ledger.Open graph →

SEC Form D · Amendment · filed March 22, 2023

Avicenna Biosciences, Inc

Offering

$41K

Sold

$27K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DURHAM, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christopher Meldrum · Durham, NCExec · Director Thomas Kaiser · Durham, NCDirector Pieter Burger · Durham, NCDirector Dennis Langer · Durham, NCDirector John Hamer · Durham, NCDirector Jonathan A. Bronson · Hingham, MAExec · Director Neil Cohen · Denver, CODirector Joshua Gruenstein · Watertown, MADirector Michael A. Harstrick · Hingham, MADirector Andrew Durgee · New York, NYDirector Greg Lyons · Dallas, TXDirector Tim Woodward · San Francisco, CAExec · Director Kenneth Hood · San Diego, CADirector Fred H. Jeffery · Safety Harbor, FLDirector Lorraine J. Hall · Matthews, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗